<DOC>
	<DOCNO>NCT01729299</DOCNO>
	<brief_summary>To determine role nutrient status ghrelin regulation insulin secretion . We hypothesize ghrelin glucagon-like peptide-1 ( GLP-1 ) ( hormone make gut , ) differential effect Î²-cell function feed state . We compare insulin secretion glucose turnover meal ingestion use dual glucose tracer mixed meal protocol subject receive ghrelin saline . We also determine role ghrelin-stimulated GLP-1 level process use GLP-1 receptor ( GLP-1R ) antagonist Exendin ( 9-39 ) ( Ex-9 ) .</brief_summary>
	<brief_title>Ghrelin Effect Beta Cell Function Health Disease</brief_title>
	<detailed_description>We plan study 20 healthy subject 4 occasion receive ghrelin , ghrelin+Ex-9 , Ex-9 saline infusion overnight fast randomized order ; Ex-9 use block GLP-1 action . A 240-minute meal tolerance test ( MTT ) use dual glucose tracer method serve foundation study visit . One tracer , [ 6,6-2H2 ] glucose infuse intravenously test meal quantify fast endogenous glucose production ( EGP ) , glucose disappearance meal . A second tracer , [ U-13C ] glucose , include meal trace appearance oral glucose . The systemic appearance rate ingest tracer total ( i.e. , ingest endogenously produce ) glucose calculate . Using protocol , able evaluate ) insulin secretion response mixed-meal ingestion , b ) glucose appearance glucose disappearance meal ingestion , c ) ghrelin effect parameter without GLP-1 , ) effect GLP-1 response base effect without Ex-9 . This dual-tracer method use assess ability individual dispose oral glucose load , accurately fractionate appearance ingest glucose plasma ( Ra meal ) , EGP , peripheral glucose disposal ( Rd ) set 41-42 . The [ 6,6-2H2 ] glucose [ U-13C ] glucose stable-isotope tracer different radioactive-isotope tracer emit radiation . All procedure perform CTRC Cincinnati Children 's Hospital Medical Center ( CCHMC ) .</detailed_description>
	<criteria>1 . Healthy men woman 2 . Ages 18 45 year 3 . BMI 18 29 kg/m2 1 . History clinical evidence impair fast glucose diabetes mellitus , myocardial infarction within past year , history symptom congestive heart failure , uncontrolled hypertension , history active liver renal disease ( AST ALT &gt; 2x upper limit normal , calculate glomerular filtration rate [ GFR ] &lt; 60 ) . 2 . History pituitary adrenal disorder neuroendocrine tumor . 3 . Anemia define hematocrit &lt; 33 % . 4 . Use medication alter glucose metabolism 5 . Pregnancy lactation . 6 . Abnormal Electrocardiogram ( ECG ) : evidence ischemia arrhythmia . 7 . Women positive pregnancy test time study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>ghrelin</keyword>
	<keyword>glucose control</keyword>
	<keyword>GLP-1</keyword>
	<keyword>Exendin ( 9-39 )</keyword>
	<keyword>insulin</keyword>
</DOC>